Clinical trial reportThe Journal of rheumatologyPublished
Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- The Journal of rheumatology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Arthritis, Psoriatic; Antirheumatic Agents; Treatment Outcome; Double-Blind Method; Antibodies, Monoclonal, Humanized; Tumor Necrosis Factor Inhibitors; Safety; Adverse effects; Psoriatic Arthritis; Biologic Therapy; Guselkumab
- PubMed ID
- 36642439
- Open access
- Yes, free to read
- Added to directory
- Source checked